JMIR Cancer

metrics 2024

Pioneering discoveries in cancer research and treatment.

Introduction

JMIR Cancer is a premier open access journal published by JMIR Publications, Inc., dedicated to advancing the field of cancer research and oncology. Since its inception in 2015, the journal has become an invaluable resource for researchers, clinicians, and students alike, providing a platform for the dissemination of cutting-edge research and clinical insights. Operating out of Canada, JMIR Cancer holds noteworthy rankings, including a Q3 position in Cancer Research and Q2 in Oncology as of 2023, highlighting its significant contribution to the scientific community. With the journal's open access model, articles are made freely available, ensuring that vital research reaches a wide audience and fosters collaboration across disciplines. By focusing on innovative research, translational studies, and clinical practices related to cancer, JMIR Cancer aims to be at the forefront of knowledge translation and tumor biology, bridging the gap between laboratory findings and patient care.

Metrics 2024

SCIMAGO Journal Rank0.79
Journal Impact Factor3.30
Journal Impact Factor (5 years)3.10
H-Index24
Journal IF Without Self3.30
Eigen Factor0.00
Normal Eigen Factor0.38
Influence0.98
Immediacy Index0.30
Cited Half Life2.80
Citing Half Life5.60
JCI0.66
Total Documents323
WOS Total Citations789
SCIMAGO Total Citations1699
SCIMAGO SELF Citations86
Scopus Journal Rank0.79
Cites / Document (2 Years)3.26
Cites / Document (3 Years)3.30
Cites / Document (4 Years)3.41

Metrics History

Rank 2024

Scopus

Oncology in Medicine
Rank #200/404
Percentile 50.50
Quartile Q2
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #148/230
Percentile 35.65
Quartile Q3

IF (Web Of Science)

ONCOLOGY
Rank 118/322
Percentile 63.50
Quartile Q2

JCI (Web Of Science)

ONCOLOGY
Rank 161/322
Percentile 50.00
Quartile Q3

Quartile History

Similar Journals

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Elevating Clinical Oncology through Rigorous Scholarship.
Publisher: SPRINGERISSN: 0171-5216Frequency: 12 issues/year

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, published by Springer, is a prestigious peer-reviewed journal dedicated to advancing the fields of cancer research and clinical oncology. With an impact factor reflecting its significance within the academic community, the journal operates under a rigorous quality standard and offers a wealth of knowledge spanning from 1979 and continuing through 2025. With its comprehensive scope, it encompasses a wide array of topics including novel therapeutic strategies, clinical trials, and cutting-edge research methodologies, making it an essential resource for researchers, practitioners, and students alike. The journal’s category quartiles highlight its competitive edge, ranking Q2 in Cancer Research and Q1 in Medicine (miscellaneous) as of 2023. This positioning underscores its role at the forefront of oncology discourse. Through this journal, contributors and readers alike engage with impactful research that informs clinical practices and enhances patient care in oncology. Access to the journal’s content, although not open access, ensures curated and high-quality insights available to the academic and professional community.

BMC Primary Care

Unlocking New Perspectives in Primary Care Dynamics
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Primary Care is a leading peer-reviewed journal published by BMC that provides a vital platform for the dissemination of research and developments in the field of primary care. Established in 2022 as an open access journal, it allows for greater accessibility and visibility of research findings. Operating from the United Kingdom, BMC Primary Care has rapidly assumed an esteemed position within the academic community, currently ranked in the Q1 category for both Family Practice and Medicine (miscellaneous) based on 2023 metrics. With a Scopus rank of #9 out of 56 in Family Practice, positioned in the 84th percentile, this journal serves as an essential resource for researchers, healthcare practitioners, and students seeking to enhance their understanding of primary care dynamics. Through a commitment to high-quality research, BMC Primary Care aims to foster innovation and effective practices that ultimately improve patient care and health outcomes.

ONCOLOGIST

Transforming insights into impactful cancer therapies.
Publisher: OXFORD UNIV PRESSISSN: 1083-7159Frequency: 12 issues/year

ONCOLOGIST is a premier, open-access journal published by Oxford University Press, advancing the field of cancer research since its inception in 1996. With an impressive H-Index and a prestigious placement within the Q1 category in Cancer Research, Medicine, and Oncology for 2023, ONCOLOGIST stands at the forefront of oncological science, boasting a Scopus rank of #55 out of 404 in Medicine and #47 out of 230 in Cancer Research. This journal not only disseminates cutting-edge research but also aims to foster multidisciplinary approaches that are critical for addressing the complex challenges faced in cancer therapy and survivorship. Be part of a vibrant community as you explore impactful research articles that contribute to the global conversation on cancer. ONCOLOGIST is dedicated to providing an accessible platform for authors and readers alike, ensuring that high-quality research is available to all stakeholders in the fight against cancer.

Frontiers in Digital Health

Pioneering Research at the Intersection of Health and Technology
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Digital Health is an innovative peer-reviewed journal published by FRONTIERS MEDIA SA, focusing on the intersection of digital technology and healthcare. As an Open Access journal since 2020, it aims to democratize knowledge by making cutting-edge research freely available to the global community. The journal covers a wide array of topics within the realms of Biomedical Engineering, Health Informatics, and a variety of Computer Science Applications, ensuring interdisciplinary collaboration and advancements. Recognized for its excellence, it holds prestigious rankings in multiple categories, including Q1 in Biomedical Engineering and Q2 in several related fields according to the 2023 metrics. Set in the heart of Switzerland, the journal fosters a comprehensive approach to enhancing digital health technologies, making it an essential resource for researchers, professionals, and students dedicated to improving health outcomes through innovation.

International Journal of E-Health and Medical Communications

Transforming healthcare through digital innovation.
Publisher: IGI GLOBALISSN: 1947-315XFrequency: 4 issues/year

Welcome to the International Journal of E-Health and Medical Communications, a pivotal publication designed to bridge the gap between health informatics and computer science applications. Published by IGI Global, this journal serves as a platform for innovative research and insights into e-health technologies, health communication strategies, and the evolving role of digital tools in enhancing healthcare delivery and management. With an ISSN of 1947-315X and E-ISSN 1947-3168, it caters to an audience keen on advancing the intersection of technology and health, as evidenced by its respectable standings in Scopus rankings—positioned in the 64th percentile in Health Informatics and 63rd in Computer Science Applications. Over its publication history from 2010 to 2024, the journal has consistently contributed to significant discussions and advancements within these fields, highlighted by its Q3 quartile ranking in 2023. Join a community of researchers, professionals, and students dedicated to the ongoing exploration of e-health, as we collectively navigate the complex landscape of healthcare innovation.

Journal of the Egyptian National Cancer Institute

Leading the charge in global cancer discourse.
Publisher: SPRINGERISSN: 1110-0362Frequency: 1 issue/year

Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.

JCO Oncology Practice

Empowering Practitioners with Insightful Oncology Solutions
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2688-1527Frequency: 6 issues/year

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

PSYCHO-ONCOLOGY

Transforming Patient Care Through Psychological Insights
Publisher: WILEYISSN: 1057-9249Frequency: 12 issues/year

PSYCHO-ONCOLOGY is a leading international journal published by Wiley, focusing on the interdisciplinary fields of psychology and oncology. Established in 1992 and continuing its impactful contributions to academic discourse through 2024, the journal occupies a prestigious position with a Q1 ranking in Experimental and Cognitive Psychology and notable placements in both Oncology and Psychiatry and Mental Health categories. With an impressive Scopus ranking that places it in the 86th and 76th percentiles within its respective fields, PSYCHO-ONCOLOGY facilitates the exploration of psychological dimensions of cancer and its treatment, emphasizing evidence-based research that greatly informs clinical practices. Researchers, professionals, and students benefit from its comprehensive scope, which encompasses mental health implications linked to cancer diagnosis, treatment, and survivorship. Although it operates on a subscription model, the journal remains a vital resource for advancing knowledge and promoting psychosocial well-being in oncology, making it an essential read for those dedicated to improving patient outcomes.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Advancing Health Through Innovative Informatics Research
Publisher: OXFORD UNIV PRESSISSN: 1067-5027Frequency: 12 issues/year

The Journal of the American Medical Informatics Association, published by Oxford University Press, stands as a premier publication within the field of Health Informatics, showcasing cutting-edge research and innovative practices. With an impressive Q1 category ranking in 2023 and a remarkable Scopus rank of #6 out of 138, this journal consistently contributes to the advancement of knowledge and application in medical informatics, making it a vital resource for researchers, healthcare professionals, and students alike. Since its inception in 1994, the journal has fostered interdisciplinary collaboration and provides a platform for high-quality research that drives improvements in healthcare practices and technology. Although it operates on a subscription model, the journal's impactful findings and comprehensive analyses are essential for those looking to stay at the forefront of health informatics innovations.

Lancet Respiratory Medicine

Empowering healthcare through exceptional respiratory research.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.